Document Detail

Predictors of pregnancy complications in women with congenital heart disease.
MedLine Citation:
PMID:  20584777     Owner:  NLM     Status:  In-Process    
AIMS: Data regarding pregnancy outcome in women with congenital heart disease (CHD) are limited.
METHODS AND RESULTS: In 1802 women with CHD, 1302 completed pregnancies were observed. Independent predictors of cardiac, obstetric, and neonatal complications were calculated using logistic regression. The most prevalent cardiac complications during pregnancy were arrhythmias (4.7%) and heart failure (1.6%). Factors independently associated with maternal cardiac complications were the presence of cyanotic heart disease (corrected/uncorrected) (P < 0.0001), the use of cardiac medication before pregnancy (P < 0.0001), and left heart obstruction (P < 0.0001). New characteristics were mechanical valve replacement (P = 0.0014), and systemic (P = 0.04) or pulmonary atrioventricular valve regurgitation related with the underlying (moderately) complex CHD (P = 0.03). A new risk score for cardiac complications is proposed. The most prevalent obstetric complications were hypertensive complications (12.2%). No correlation of maternal characteristics with adverse obstetric outcome was found. The most prevalent neonatal complications were premature birth (12%), small for gestational age (14%), and mortality (4%). Cyanotic heart disease (corrected/uncorrected) (P = 0.0003), mechanical valve replacement (P = 0.03), maternal smoking (P = 0.007), multiple gestation (P = 0.0014), and the use of cardiac medication (P = 0.0009) correlated with adverse neonatal outcome.
CONCLUSION: In our tertiary CHD cohort, cardiac, obstetric, and neonatal complications were frequently encountered, and (new) correlations of maternal baseline data with adverse outcome are reported. A new risk score for adverse cardiac complications is proposed, although prospective validation remains necessary.
Willem Drenthen; Eric Boersma; Ali Balci; Philip Moons; Jolien W Roos-Hesselink; Barbara J M Mulder; Hubert W Vliegen; Arie P J van Dijk; Adriaan A Voors; Sing C Yap; Dirk J van Veldhuisen; Petronella G Pieper;
Related Documents :
24663157 - Comparison of a 16- versus a 19-day interval between controlled internal drug release r...
17203797 - Heart diseases during pregnancy.
21210447 - Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophys...
15328487 - Total body water estimation and maternal cardiac systolic function assessment in normal...
9014397 - Preliminary evaluation of safety aspects of neem oil in kerosene lamp.
19584727 - Prevention of complete heart block in children of mothers with anti-ssa/ro and anti-ssb...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-06-28
Journal Detail:
Title:  European heart journal     Volume:  31     ISSN:  1522-9645     ISO Abbreviation:  Eur. Heart J.     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-09-02     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8006263     Medline TA:  Eur Heart J     Country:  England    
Other Details:
Languages:  eng     Pagination:  2124-32     Citation Subset:  IM    
Department of Cardiology, University Medical Centre Groningen, University of Groningen, PO Box 30.001, 9700 RB Groningen, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Instantaneous coronary collateral function during supine bicycle exercise.
Next Document:  How to calculate vascular age with the SCORE project scales: a new method of cardiovascular risk eva...